Literature DB >> 20565491

A prospective evaluation of hemoptysis cases in a tertiary referral hospital.

Oğuz Uzun1, Yildiz Atasoy, Serhat Findik, Atilla Güven Atici, Levent Erkan.   

Abstract

BACKGROUND AND AIMS: Hemoptysis is symptomatic of a potentially serious and life-threatening thoracic disease. The purpose of this study was to evaluate the relative frequency of the different causes of hemoptysis, the change of the frequency of diseases, the value of the evaluation process and the outcome in a tertiary referral hospital.
METHODS: A prospective study was carried out on consecutive patients presented with hemoptysis.
RESULTS: A total of 178 patients (136 male, 42 female) were included to the study. Lung cancer (51), pulmonary embolism (23) and bronchiectasis (23) constituted most of the diagnosis. The most frequent cause of hemoptysis in males was by far lung carcinoma (50). Twelve cases of bronchiectasis and 11 cases of pulmonary embolism were observed in females. While lung cancer and pulmonary embolism were associated with mild to moderate amounts of bleeding (84% and 100%, respectively), patients with active tuberculosis and pulmonary vasculitis had severe to massive hemoptysis (50% and 44%, respectively). Transthoracic and other organ biopsies, spiral computed tomography (CT) angiography (X pres/GX model TSX-002a, Toshiba, Tochigi Ken, Japan) and aortography yielded high diagnostic results in our group (100%, 67%, 59% and 100%, respectively). The most frequent final diagnosis in patients with normal chest radiograph was pulmonary embolism (seven cases).
CONCLUSIONS: Lung cancer, pulmonary embolism and bronchiectasis were the main causes of hemoptysis in this prospective cohort; however, this is the first report showing pulmonary embolism as a leading cause of hemoptysis. CT angiography with high-resolution CT should be the primary diagnostic modality if the initial investigation is inconclusive in hemoptysis cases.

Entities:  

Mesh:

Year:  2010        PMID: 20565491     DOI: 10.1111/j.1752-699X.2009.00158.x

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  10 in total

Review 1.  Systematic review of guidelines for the management of suspected lung cancer in primary care.

Authors:  M Elisabeth Del Giudice; Sheila-Mae Young; Emily T Vella; Marla Ash; Praveen Bansal; Andrew Robinson; Roland Skrastins; Yee Ung; Robert Zeldin; Cheryl Levitt
Journal:  Can Fam Physician       Date:  2014-08       Impact factor: 3.275

2.  Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review.

Authors:  Stephen H Bradley; Sarah Abraham; Matthew Ej Callister; Adam Grice; William T Hamilton; Rocio Rodriguez Lopez; Bethany Shinkins; Richard D Neal
Journal:  Br J Gen Pract       Date:  2019-11-28       Impact factor: 5.386

Review 3.  Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts.

Authors:  M Reck; F Barlesi; L Crinò; C I Henschke; D Isla; S Stiebeler; D R Spigel
Journal:  Ann Oncol       Date:  2011-11-04       Impact factor: 32.976

4.  Massive hemoptysis due to welding fumes.

Authors:  Oğuz Uzun; Ozgur İnce; Veli Bakalov; Tibel Tuna
Journal:  Respir Med Case Rep       Date:  2012-02-01

5.  Suspected cancer diagnoses made by general practitioners in a population with subsequently confirmed cancer diagnoses in Germany: a retrospective study of 31,628 patients.

Authors:  Karel Kostev; Uwe Meister; Matthias Kalder; Louis Jacob
Journal:  Oncotarget       Date:  2017-09-14

6.  Risk of cancer in patients with epistaxis and haemoptysis.

Authors:  Anne G Ording; Katalin Veres; Dóra K Farkas; Kasper Adelborg; Henrik T Sørensen
Journal:  Br J Cancer       Date:  2018-02-20       Impact factor: 7.640

7.  Hemoptysis with no malignancy suspected on computed tomography rarely requires bronchoscopy.

Authors:  Christian Lund Petersen; Ulla Møller Weinreich
Journal:  Eur Clin Respir J       Date:  2020-02-06

8.  Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection.

Authors:  P Hu; G Wang; H Cao; H Ma; P Sui; J Du
Journal:  Br J Cancer       Date:  2013-08-20       Impact factor: 7.640

9.  Bronchoscopy as a supplement to computed tomography in patients with haemoptysis may be unnecessary.

Authors:  Klaus Nielsen; Magnus Gottlieb; Sara Colella; Zaigham Saghir; Klaus R Larsen; Paul F Clementsen
Journal:  Eur Clin Respir J       Date:  2016-06-23

10.  Long-term prognostic outcomes in patients with haemoptysis.

Authors:  Michele Mondoni; Paolo Carlucci; Giuseppe Cipolla; Matteo Pagani; Francesco Tursi; Alessandro Fois; Pietro Pirina; Sara Canu; Stefano Gasparini; Martina Bonifazi; Silvia Marani; Andrea Comel; Laura Saderi; Sabrina De Pascalis; Fausta Alfano; Stefano Centanni; Giovanni Sotgiu
Journal:  Respir Res       Date:  2021-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.